—

Samsara BioCapital, LLC

Q1 2026 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    22

  • Value ($000)

    $1,029,103

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
S
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$339.09M
33 %

6,897,652

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$159.05M
16 %

5,871,018

A
ALMS

ALUMIS INC

COM
022307102
$139.79M
14 %

6,345,219

---

SEPTERNA INC

COM
81734D104
$75.67M
7 %

3,149,128

---

KALARIS THERAPEUTICS INC

COM
482929106
$74.71M
7 %

12,948,081

---

SPYGLASS PHARMA INC

COM SHS
85220G109
$54.67M
5 %

2,109,953

N
NGNE

NEUROGENE INC

COM
64135M105
$34.62M
3 %

1,717,127

I
IVA

INVENTIVA SA

ADS
46124U107
$28.83M
3 %

5,194,805

---

SUTRO BIOPHARMA INC

COM SHS
869367201
$26.48M
3 %

1,062,872

---

JADE BIOSCIENCES INC

COM NEW
008064206
$13.61M
1 %

968,798

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 22